Lantheus Holdings, Inc.
Company Stats
- Market Cap
- $6.5B
- as of Sep 30, 2026
- Shares Outstanding
- 65.3M
- Free Float
- 92.9%
Income Statement
- Revenue
- $1.5B
- Operating Income
- $310.8M
- Net Income
- $233.6M
- EBITDA
- $380.9M
- Revenue Growth, 3Y
- 18.1%
- FCF Margin, 3Y Avg
- 26.8%
- FCF Margin, Worst Year
- 20.0%
Cash Flow
- Free Cash Flow
- $386.7M
- FCF Yield
- 6.0%
- Owner FCF Yield
- 4.6%
Balance Sheet
- Cash & Equivalents
- $359.1M
Returns & Capital
- Share Repurchases
- $300.0M
- Buyback Yield, 3Y Avg
- 2.1%
- SBC, 3Y Avg
- $70.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.5B | $386.7M | 25.1% |
| FY2024 | $1.5B | $539.7M | 35.2% |
| FY2023 | $1.3B | $259.9M | 20.0% |
| FY2022 | $935.1M | $21.8M | 2.3% |
| FY2021 | $425.2M | $53.9M | 12.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
October 23, 2026
Deal Scrutiny
FTC second request extends review of Curium-Lantheus deal
October 2, 2026
Deal Scrutiny
Curium refiles for Lantheus Holdings, Inc. (LNTH) acquisition
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 3, 2026
Deals
Curium to Buy Lantheus in $8 Billion Cash-and-CVR Deal
FTC second request extends review of Curium-Lantheus deal
October 2, 2026
Deal Scrutiny
Curium refiles for Lantheus Holdings, Inc. (LNTH) acquisition
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 3, 2026
Deals
Curium to Buy Lantheus in $8 Billion Cash-and-CVR Deal